
View larger version (26K):
[in this window]
[in a new window]
|
Figure. Screening for gestational diabetes mellitus (GDM): clinical summary of U. S. Preventive Services Task Force Recommendation.
For a summary of the evidence systematically reviewed in making these recommendations, the full recommendation statement (including a summary of research gaps), and supporting documents, please go to http://www.preventiveservices.ahrq.gov. *The current evidence is insufficient to establish the balance of benefits and harms for screening for gestational diabetes mellitus, either before or after 24 weeks' gestation.
|